Clinical and biological aspects of disseminated tumor cells and dormancy in breast cancer
Progress in detection and treatment have drastically improved survival for early breast
cancer patients. However, distant recurrence causes high mortality and is typically …
cancer patients. However, distant recurrence causes high mortality and is typically …
Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment
Y Bi, J Chen, Q Li, Y Li, L Zhang, L Zhida, F Yuan… - Iscience, 2024 - cell.com
Tumor extracellular vesicles (EVs) demonstrate considerable promise for medication
delivery and tumor targeting owing to their natural long-term blood circulation and tissue …
delivery and tumor targeting owing to their natural long-term blood circulation and tissue …
Recent advances in lab-on-a-chip systems for breast cancer metastasis research
B Firatligil-Yildirir, O Yalcin-Ozuysal - Nanoscale Advances, 2023 - pubs.rsc.org
Breast cancer is the leading cause of cancer-related deaths in women. Multiple molecular
subtypes, heterogeneity, and their ability to metastasize from the primary site to distant …
subtypes, heterogeneity, and their ability to metastasize from the primary site to distant …
Therapeutics targeting the metastatic breast cancer bone microenvironment
CL Ihle, SJ Wright-Hobart, P Owens - Pharmacology & Therapeutics, 2022 - Elsevier
Breast cancer (BC) patient prognosis has improved over the past 2 decades with a 99% 5-
year survival rate for localized BC, yet metastatic breast cancer (mBC) continues to cause …
year survival rate for localized BC, yet metastatic breast cancer (mBC) continues to cause …
Inflammation, nutrition, and clinical outcomes in breast cancer survivors: A narrative review
MK Pannu, C Constantinou - Current Nutrition Reports, 2023 - Springer
Abstract Purpose of Review Breast cancer (BC) is the leading cause of death among women
aged 44–55 years globally. Pro-inflammatory food can cause tissue-level inflammation …
aged 44–55 years globally. Pro-inflammatory food can cause tissue-level inflammation …
Polyethyleneimine-based lipopolyplexes as carriers in anticancer gene therapies
J Jerzykiewicz, A Czogalla - Materials, 2021 - mdpi.com
Recent years have witnessed rapidly growing interest in application of gene therapies for
cancer treatment. However, this strategy requires nucleic acid carriers that are both effective …
cancer treatment. However, this strategy requires nucleic acid carriers that are both effective …
High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues
Purpose The aberrant mRNA expression of a UPR component Cation transport regulator
homolog 1 (CHAC1) has been reported to be associated with poor survival in breast and …
homolog 1 (CHAC1) has been reported to be associated with poor survival in breast and …
“Cluster Bomb” Based Bismuth Nano‐in‐Micro Spheres Formed Dry Powder Inhalation for Thermo‐Radio Sensitization Effects of Lung Metastatic Breast Cancer
Lung metastatic breast cancer (LMBC) is mainly diagnosed through CT imaging and
radiotherapy could be the most common method in the clinic to inhibit tumor proliferation …
radiotherapy could be the most common method in the clinic to inhibit tumor proliferation …
Timing evolution of lobular breast cancer through phylogenetic analysis
Background Late distant recurrence is a challenge for the treatment of invasive lobular
carcinoma (ILC) of the breast. Despite in-depth characterisation of primary ILC, the …
carcinoma (ILC) of the breast. Despite in-depth characterisation of primary ILC, the …
ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis
EM Meškytė, L Pezzè, L Bartolomei, M Forcato… - Cell Death & …, 2023 - nature.com
The transcription factor ETV7 is an oncoprotein that is up-regulated in all breast cancer (BC)
types. We have recently demonstrated that ETV7 promoted breast cancer progression by …
types. We have recently demonstrated that ETV7 promoted breast cancer progression by …